{
    "2018-11-28": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "LLY",
                        "Outpacing",
                        "Medical Peers"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial",
                "features": {
                    "keywords": [
                        "Zafgen",
                        "ZFGN",
                        "Plunges",
                        "FDA",
                        "Hold",
                        "Diabetes Drug",
                        "Trial"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}